氨酸I在老鼠中的药理动力学和代谢
Ashley Roberts1, Nicole Cuellar-Kingston2, Steven Townley3
1AR Toxicology, Toronto, ON, Canada.
Toxicology reports
|January 8, 2026
概括
氨酸I很快被排出,主要是通过便,在老鼠中系统吸收和暴露低. 在吸收之前,对mogrol的新陈代谢发生在肠道中,并进一步氧化吸收的化合物.
科学领域:
- 药理动力学和新陈代谢
- 药物开发 药物开发
- 自然产品化学 自然产品化学
背景情况:
- 氨酸I是一种具有潜在治疗应用的化合物.
- 了解它的吸收,分布,新陈代谢和分泌 (ADME) 对于它的发展至关重要.
研究的目的:
- 在大鼠中研究[14C]-胺酸I的药理动力学和代谢.
- 为了确定主要的排泄途径,以及吸收程度和全身暴露.
主要方法:
- 单次口服[14C]-胺酸I (5毫克/千克) 给完好无损的和胆道通道通道的雄性和雌性大鼠.
- 量化尿液,便,血液,血,组织和胆汁中的放射性.
- 在排泄物和血中识别主要代谢物.
主要成果:
- 放射性物质在168小时内迅速和几乎完全消除,主要通过便 (92-101%).
- 低的系统吸收 (大约. 42-43%) 和低系统性暴露 (1-1.5%在尿液中).
- 在胃肠道中进行前吸收代谢到mogrol,并进一步氧化吸收的mogrol.
结论:
- 氨酸I经历了显著的系统前代谢转化为mogrol.
- 该化合物迅速清除,系统吸收和暴露有限.
- 没有观察到在组织中积累或保留的证据.
相关概念视频
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism
194
Geriatric patients show significant variation in how their bodies process medications, which can change how effective and safe treatments are. The liver is the primary organ where drug metabolism occurs, involving two main types of chemical reactions: phase I and II. Phase I metabolism is driven by the cytochrome P450 enzyme system, which includes key types such as CYP3A, CYP2D6, and CYP2C9. Research indicates that while aging doesn't notably alter the levels or activity of these enzymes, it...
194
Nonlinear Pharmacokinetics: Dependence of Elimination Half-Life and Dose Clearance
630
The elimination half-life and drug clearance of drugs following nonlinear kinetics can vary with dosage. The Michaelis-Menten parameters and drug concentration influence these factors. As the dose increases, the elimination half-life tends to lengthen, resulting in a reduction in clearance and a disproportionately larger area under the curve. The total clearance can be derived from the Michaelis-Menten equation for drugs following a one-compartment model.
A study on guinea pigs examined the...
A study on guinea pigs examined the...
630
Pharmacokinetics in Pediatric Patients: Drug Metabolism
189
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
189
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion
165
Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
165
Methods for Studying Drug Absorption: In situ
624
In situ experiments, such as the Doluisio method and Single-Pass Perfusion technique, provide critical insights into drug uptake by simulating in vivo conditions for drug absorption.
The Doluisio method involves perfusing a prepared segment of a rat's small intestine with a solution of radiolabeled drug and a non-absorbable marker. This helps to differentiate between absorbed and non-absorbed drug concentrations. The intestinal segment is connected at both ends using tubing and syringes,...
The Doluisio method involves perfusing a prepared segment of a rat's small intestine with a solution of radiolabeled drug and a non-absorbable marker. This helps to differentiate between absorbed and non-absorbed drug concentrations. The intestinal segment is connected at both ends using tubing and syringes,...
624
Drug Metabolism: Phase II Reactions
4.8K
Phase II reactions are essential for the detoxification and elimination of drugs from the body. These reactions involve the conjugation of parent drugs or their phase I metabolites with endogenous molecules, resulting in more hydrophilic drug conjugates. The primary conjugation reactions in this phase are sulfation and glucuronidation. Both sulfation and glucuronidation typically produce biologically inactive metabolites. However, in some cases involving prodrugs, active metabolites may be...
4.8K


